Wikidata

(Q63805789)

English

Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide

clinical trial

In more languages

Statements

title
Haploidentical Transplant for Patients With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide (English)
0 references
start time
8 May 2019
0 references
end time
15 June 2034
0 references
number of participants
30
0 references
research intervention
(RS)-cyclophosphamide
0 references
sirolimus
0 references
busulfan
0 references
alemtuzumab
0 references
minimum age
4 year
0 references
maximum age
65 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63805789&oldid=1857361773"